论文部分内容阅读
AIM: Peroxisome proliferator-activated receptor γ (PPARγ) is known to regulate growbh arrest and terminal differentiation of adipocytes and is used clinically as a new class of antidiabetic drugs. Recently, several studies have reported that treatment of